## Abstract The usefulness of fully automated chemiluminescent microparticle immunoassay (Architect HBsAg QT) for monitoring serum levels of hepatitis B virus (HBV) during antiviral therapy remains unclear. Using this assay, hepatitis B surface antigen (HBsAg) was measured in 20 patients with chron
Lamivudine treatment of chronic hepatitis B
β Scribed by Geoffrey Dusheiko
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 142 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1052-9276
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The aim of this study was to elucidate the longβterm outcome after interferon (IFN) or lamivudine (LMV) treatment in Japanese patients with hepatitis B e antigen (HBeAg) positive chronic hepatitis B. Inclusion criteria were biopsy proven chronic hepatitis or liver cirrhosis, no history
We have previously demonstrated that combination peginterferon and lamivudine treatment has superior antiviral efficacy to lamivudine monotherapy in chronic hepatitis B. In this study, we investigated the long-term posttreatment virological response to this combination treatment. Sustained virologic